Exagen, Inc. (XGN)
6.99
-0.21
(-2.92%)
USD |
NASDAQ |
Dec 08, 16:00
6.995
0.00 (0.00%)
After-Hours: 20:00
Exagen Shareholders Equity (Quarterly): 18.14M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| FONAR Corp. | 174.87M |
| XWELL, Inc. | -6.333M |
| ProPhase Labs, Inc. | 6.861M |
| Veracyte, Inc. | 1.258B |
| Insight Molecular Diagnostics, Inc. | -9.196M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 62.82M |
| Total Liabilities (Quarterly) | 44.68M |
| Debt to Equity Ratio | 1.553 |
| Current Ratio | 4.080 |
| Net Debt Paydown Yield | -0.35% |